47045-BLR-C-UNDP-1 The Global Fund to Fight AIDS, Tuberculosis and Malaria <narrative>Strengthening of HIV and tuberculosis (“TB”) national systems of prevention, treatment, care and support in the Republic of Belarus - Phase 2 - Belarus (01-Nov-2022-31-Dec-2024)</narrative> Belarus, TB/HIV, United Nations Development Programme Goal: To support Belarus in implementing the updated national TB and HIV strategies for the period of 2021-2025 in order to decrease the burden and suffering caused by HIV infection and TB, to improve enabling environment and systems that are people-centered for effective and sustainable response to HIV and TB challenges in the country. Objectives: Close the gap in achieving 95-95-95 targets: increase early HIV detection, rapid initiation of ART and improve quality of care; Reduce new HIV transmissions; Improve access to early diagnostics, including WHO-recommended rapid diagnostic methods; Improve treatment outcomes through expanding access to WHO-recommended MDR TB treatment regimens and adherence support; Expand coverage with TB preventive treatment in all key groups; Zero discrimination and remove human rights and gender barriers; Leverage health and community system resources to sustain delivery of high coverage, quality HIV and TB services. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme United Nations Development Programme The Global Fund to Fight AIDS, Tuberculosis and Malaria The Global Fund to Fight AIDS, Tuberculosis and Malaria Communications +41 58 791 1700 website@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland The Global Fund to Fight AIDS, Tuberculosis and Malaria Grant Management Division xxxx xxxx Fund Portfolio Manager +41 58 791 1700 xxxx https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland Belarus HIV Multicomponent, RSSH Tuberculosis Ensure healthy lives and promote well-being for all at all ages End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases Achieve universal health coverage HIV -> Differentiated HIV Testing Services -> Community-based testing HIV -> Differentiated HIV Testing Services -> Facility-based testing HIV -> Differentiated HIV Testing Services -> Self-testing HIV -> Prevention -> Behavior change interventions HIV -> Prevention -> Condom and lubricant programming HIV -> Prevention -> Needle and syringe programs HIV -> Prevention -> Opioid substitution therapy and other medically assisted drug dependence treatment HIV -> Prevention -> Sexual and reproductive health services, including STIs HIV -> Reducing human rights-related barriers to HIV/TB services -> HIV and HIV/TB-related legal services HIV -> Reducing human rights-related barriers to HIV/TB services -> Sensitization of law-makers and law-enforcement agents HIV -> Reducing human rights-related barriers to HIV/TB services -> Stigma and discrimination reduction (HIV/TB) HIV -> Treatment, care and support -> Counseling and psycho-social support HIV -> Treatment, care and support -> Differentiated ART service delivery and HIV care HIV -> Treatment, care and support -> Treatment monitoring - Viral load Multicomponent -> Program management -> Grant management RSSH -> RSSH: Community systems strengthening -> Community-based monitoring RSSH -> RSSH: Community systems strengthening -> Institutional capacity building, planning and leadership development RSSH -> RSSH: Community systems strengthening -> Social mobilization, building community linkages and coordination RSSH -> RSSH: Health management information systems and M&E -> Program and data quality RSSH -> RSSH: Health management information systems and M&E -> Surveys RSSH -> RSSH: Health sector governance and planning -> National health sector strategies and financing RSSH -> RSSH: Human resources for health, including community health workers -> In-service training (excluding community health workers) Tuberculosis -> MDR-TB -> Case detection and diagnosis (MDR-TB) Tuberculosis -> MDR-TB -> Key populations (MDR-TB) - Prisoners Tuberculosis -> MDR-TB -> Treatment (MDR-TB) Tuberculosis -> TB care and prevention -> Prevention (TB care and prevention) Tuberculosis -> TB care and prevention -> Treatment (TB care and prevention) 8183691.82 11098934.41 4041735.35 20855499.00 Global Fund commitment to BLR-C-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 508489.00 Global Fund disbursement to BLR-C-UNDPP01 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 4708312.00 Global Fund disbursement to BLR-C-UNDPP01 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 4495424.00 Global Fund disbursement to BLR-C-UNDPP01 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 2490194.00 Global Fund disbursement to BLR-C-UNDPP01 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 310257.00 Global Fund disbursement to BLR-C-UNDPP01 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 1395199.00 Global Fund disbursement to BLR-C-UNDPP01 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 1530006.00 Global Fund disbursement to BLR-C-UNDPP01 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 2661214.00 Global Fund disbursement to BLR-C-UNDPP01 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 4463570.41 Global Fund commitment to BLR-C-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme -2261860.00 Global Fund commitment to BLR-C-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 3035361.85 Global Fund disbursement to BLR-C-UNDPP01 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 1240957.56 Global Fund disbursement to BLR-C-UNDPP01 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 29036.00 Funds returned to the Global Fund from BLR-C-UNDPP01 (Multilateral). United Nations Development Programme The Global Fund to Fight AIDS, Tuberculosis and Malaria -29036.00 Global Fund commitment to BLR-C-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 494544.00 Global Fund disbursement to BLR-C-UNDPP01 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 2289241.84 Funds returned to the Global Fund from BLR-C-UNDPP01 (Multilateral). United Nations Development Programme The Global Fund to Fight AIDS, Tuberculosis and Malaria -2289241.84 Global Fund commitment to BLR-C-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 15134.52 Funds returned to the Global Fund from BLR-C-UNDPP01 (Multilateral). United Nations Development Programme The Global Fund to Fight AIDS, Tuberculosis and Malaria -15134.52 Global Fund commitment to BLR-C-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 5470010.01 Expenditure reported by United Nations Development Programme for BLR-C-UNDPP01, Nov 2022 to Dec 2023. United Nations Development Programme 9863436.87 Expenditure reported by United Nations Development Programme for BLR-C-UNDPP01, Jan 2024 to Dec 2024. United Nations Development Programme 452386.17 Expenditure reported by United Nations Development Programme for BLR-C-UNDPP01, Jan 2025 to Jun 2025. United Nations Development Programme 1880092.00 Expenditure reported by United Nations Development Programme for BLR-C-UNDPP01, Jul 2025 to Dec 2025. United Nations Development Programme <narrative>Grant page on the data explorer of the Global Fund.</narrative> An overview of a grant over its lifetime. <narrative>Grant terms and conditions.</narrative> General terms and conditions which apply to Global Fund grants. <narrative>Percentage of men who have sex with men that have received an HIV test during the reporting period and know their results</narrative> Module: Differentiated HIV Testing Services. <narrative>Percentage of men who have sex with men that have received an HIV test during the reporting period and know their results</narrative> Geographic coverage: National, 100% of national program target. Numerator: 8519; Denominator: 31500. Numerator: 14200; Denominator: 32000. Numerator: 11835; Denominator: 32000. Numerator: 14400; Denominator: 32000. Numerator: 12012; Denominator: 32000. <narrative>Percentage of people newly diagnosed with HIV initiated on ART</narrative> Module: Differentiated HIV Testing Services. <narrative>Percentage of people newly diagnosed with HIV initiated on ART</narrative> Geographic coverage: National, 100% of national program target. Numerator: 1053; Denominator: 1426. Numerator: 528; Denominator: 580. Numerator: 1220; Denominator: 1463. Numerator: 430; Denominator: 470. Numerator: 1108; Denominator: 1228. <narrative>Percentage of people who inject drugs that have received an HIV test during the reporting period and know their results</narrative> Module: Differentiated HIV Testing Services. <narrative>Percentage of people who inject drugs that have received an HIV test during the reporting period and know their results</narrative> Geographic coverage: National, 100% of national program target. Numerator: 14443; Denominator: 66500. Numerator: 38198; Denominator: 80000. Numerator: 33831; Denominator: 80000. Numerator: 40200; Denominator: 80000. Numerator: 36378; Denominator: 80000. <narrative>Percentage of sex workers that have received an HIV test during the reporting period and know their results</narrative> Module: Differentiated HIV Testing Services. <narrative>Percentage of sex workers that have received an HIV test during the reporting period and know their results</narrative> Geographic coverage: National, 100% of national program target. Numerator: 6317; Denominator: 19700. Numerator: 8520; Denominator: 18600. Numerator: 8878; Denominator: 18600. Numerator: 8700; Denominator: 18600. Numerator: 9445; Denominator: 18600. <narrative>Percentage of transgender people that have received an HIV test during the reporting period and know their results</narrative> Module: Differentiated HIV Testing Services. <narrative>Percentage of transgender people that have received an HIV test during the reporting period and know their results</narrative> Geographic coverage: Subnational, 100% of national program target. Numerator: 29. Numerator: 296; Denominator: 3742; Percentage: 7.9%. Numerator: 276; Denominator: 3742; Percentage: 7.38%. Numerator: 433; Denominator: 3742; Percentage: 11.57%. <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative> Module: MDR-TB. <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative> Geographic coverage: National, 100% of national program target. <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative> Module: MDR-TB. <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative> Geographic coverage: National, 100% of national program target. <narrative>Percentage of individuals receiving Opioid Substitution Therapy who received treatment for at least 6 months</narrative> Module: Prevention. <narrative>Percentage of individuals receiving Opioid Substitution Therapy who received treatment for at least 6 months</narrative> Geographic coverage: National, 100% of national program target. Numerator: 30; Denominator: 65. Numerator: 100; Denominator: 154. Numerator: 38; Denominator: 65. Numerator: 280; Denominator: 373. Numerator: 41; Denominator: 66. <narrative>Percentage of men who have sex with men reached with HIV prevention programs</narrative> Module: Prevention. <narrative>Percentage of men who have sex with men reached with HIV prevention programs</narrative> Geographic coverage: National, 100% of national program target. Numerator: 12978; Denominator: 31500. Numerator: 18543; Denominator: 32000. Numerator: 15878; Denominator: 32000. Numerator: 19399; Denominator: 32000. Numerator: 15891; Denominator: 32000. <narrative>Percentage of people who inject drugs reached with HIV prevention programs</narrative> Module: Prevention. <narrative>Percentage of people who inject drugs reached with HIV prevention programs</narrative> Geographic coverage: National, 100% of national program target. Numerator: 51201; Denominator: 66500. Numerator: 60000; Denominator: 80000. Numerator: 64343; Denominator: 80000. Numerator: 60500; Denominator: 80000. Numerator: 64756; Denominator: 80000. <narrative>Percentage of sex workers reached with HIV prevention programs</narrative> Module: Prevention. <narrative>Percentage of sex workers reached with HIV prevention programs</narrative> Geographic coverage: National, 100% of national program target. Numerator: 10021; Denominator: 19700. Numerator: 11200; Denominator: 18600. Numerator: 13792; Denominator: 18600. Numerator: 11700; Denominator: 18600. Numerator: 13857; Denominator: 18600. <narrative>Percentage of transgender people reached with HIV prevention programs - defined package of services</narrative> Module: Prevention. <narrative>Percentage of transgender people reached with HIV prevention programs - defined package of services</narrative> Geographic coverage: Subnational, 100% of national program target. Numerator: 47. Numerator: 335; Denominator: 3742; Percentage: 9%. Numerator: 330; Denominator: 3742; Percentage: 8.82%. Numerator: 332; Denominator: 3742; Percentage: 8.87%. <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative> Module: TB care and prevention. <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative> Geographic coverage: National, 100% of national program target. <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative> Module: TB/HIV. <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative> Geographic coverage: National, 100% of national program target. Numerator: 122; Denominator: 135. Numerator: 116; Denominator: 126. Numerator: 73; Denominator: 80. <narrative>Percentage of people on ART among all people living with HIV at the end of the reporting period</narrative> Module: Treatment, care and support. <narrative>Percentage of people on ART among all people living with HIV at the end of the reporting period</narrative> Geographic coverage: National, 100% of national program target. Numerator: 18765; Denominator: 28000. Numerator: 22932; Denominator: 28000. Numerator: 21931; Denominator: 27000. Numerator: 23699; Denominator: 28000. Numerator: 22792; Denominator: 27000.